#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acromegaly Measles Juvenile psoriatic arthritis Acute myeloid leukaemia recurrent Neuroendocrine cell hyperplasia of infancy Malignant neoplasm of choroid Oesophageal atresia Dupuytren's contracture Juvenile idiopathic arthritis Epileptic encephalopathy Neonatal alloimmune thrombocytopenia Breast cancer Congenital myopathy Ewing's sarcoma metastatic Pouchitis More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Trials in Disease SAPHO syndrome – Basic Information Osteosarcoma – Trials in Disease Lymphatic malformation – Trials in Disease Angiosarcoma recurrent – Trials in Disease Breast angiosarcoma – Basic Information Glomerulonephritis membranoproliferative – Trials in Disease X-linked lymphoproliferative syndrome – Basic Information Skin angiosarcoma – Diagnostics Congenital nephrogenic diabetes insipidus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Plitidepsin Odm-111 L-PHENYLALANINE Mps-216 SIPAVIBART Maridebart Cafraglutide Landiolol Hydrochloride SEVUPARIN L-Histidine Hydrochloride Isis 696844 Ketamine Hydrochloride Deferoxamine Mesilate WEF-001 Gen1047 Aliskiren METAMIZOLE SODIUM Meclofenamate Sodium Bcmacp03 Corylus Avellana L. Eplontersen More therapies…

    Learn about Your Condition

    Pustular psoriasis Thyroid cancer Primary hyperthyroidism Portal hypertension Neurofibromatosis Colorectal adenoma Diphtheria Menopause HER2 protein overexpression Lymphocyte adoptive therapy Ischaemic stroke Hand dermatitis Senile dementia Crigler-Najjar syndrome Extraskeletal ossification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of Oral Minoxidil for Women with Androgenetic Alopecia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Androgenetic alopecia
    Investigated Drugs:
    • Minoxidil
    Germany Italy Portugal Spain

  • Study on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot infection
    Investigated Drugs:
    • F1245/05
    • F125/10
    • F44/10
    Poland

  • Study on Tofacitinib for Patients with Mycosis Fungoides

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Tofacitinib
    Denmark

  • Study on Optimizing Ciclosporin Treatment for Moderate to Severe Atopic Dermatitis in Adults, Adolescents, and Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Ciclosporin
    Spain

  • Study on Treating Keratolytic Winter Erythema in Adults Using Nitroxoline

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Erythema
    Norway

  • Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Bi 685509
    Austria Belgium Czechia Denmark Finland France +11
Previous Page
1 … 57 58 59 60 61 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!